joe rogan huberman bpc 157 Experience #1842 Comment ANSWERS and I’ll DM

The Phase IIb trial did not meet its primary fat-loss endpoint, and all benefit claims must be understood within the context of the evidence tier from which they derive

GHK-Cu is a research peptide and is not FDA approved for injection

Organ protection studies in animal models of chemotherapy-induced damage and traumatic brain injury show BPC-157's cytoprotective reach across multiple tissue types

Extended heat exposure can cause: Color darkening or brownish shifts Cloudiness from peptide aggregation Visible particle formation Loss of potency even without visible changes If your medication was shipped without adequate cold chain protection, or if it sat in a hot mailbox or delivery vehicle for hours, inspect it carefully before use

Scientists were then able to create synthetic T1

PDA + GHK-Cu protocol: PDA: 500 mcg subcutaneous or oral, once daily GHK-Cu: Per standard dosing guidelines (varies by administration route) Duration: 4 to 8 weeks PDA + SS-31 (Elamipretide) For researchers focused on mitochondrial health and cellular energy, combining penta deca peptide arginate with SS-31 creates a protocol that addresses tissue repair from both structural and energetic perspectives